[professionals/dropdownmaster.htm]

For Professionals Professional Membership Healthcare Professional Advocate Professional E-Newsletter Osteoporosis International Subscription Education Events Resources and Publications Continuing Education Opportunities Special Projects Research Grant Program Patient and Consumer Resources Subscribe to NOF's Professional Activities 8th International Symposium on Osteoporosis: Translating Research into Clinical Practice April 1 – 5, 2009 Marriott Wardman Park Hotel, Washington, DC Symposium Purpose The National Osteoporosis Foundation (NOF)-sponsored International Symposium on Osteoporosis (ISO) is designed to provide the most current and clinically relevant evidence-based information on the prevention, diagnosis, and treatment of osteoporosis.  This will be accomplished through in-depth educational sessions addressing primary and secondary osteoporosis, clinical considerations and therapeutics, socio-behavioral medicine, nutrition, education, epidemiology, pathophysiology, genetics and emerging science. In the U.S. today, ten million individuals already have osteoporosis and 34 million more have low bone mass, placing them at increased risk for the disease and related fractures.  One in two women and one in four men age 50 and older are at risk for an osteoporosis-related fracture in their lifetime.  The disease affects people of all ethnic backgrounds.  Increased life expectancy puts greater numbers at risk for osteoporosis, the need for early and accurate diagnosis becomes more critical.  While osteoporosis can be reliably diagnosed, treated and prevented if often goes undetected in patients, leading to severe physical, social, functional and psychological consequences including increased mortality and morbidity.  Thus, improving the diagnosis and treatment of osteoporosis is a major challenge and priority for healthcare professionals.  The programs that comprise the 8th International Symposium stress the practical application of science and research to the clinical management of patients with osteoporosis and low bone mass.       Program Wednesday, April 1, 2009 2:00 p.m. Hands on Workshops Using Fracture Risk Assessment in Your Practice, Marjorie Luckey, MD  Pharmacological Treatments for Osteoporosis: Past, Present and Future, E. Michael Lewiecki, MD Thursday, April 2, 2009 8:00 a.m. Lessons from Space Travel for Improving Bone Health on Earth, Peter Cavanagh, PhD 9:30 a.m. Poster Presentations and Exhibit Hall Break 10:30 a.m. Plenary Osteoporosis: Secondary Causes of Bone Loss Determining Secondary Causes of Osteoporosis, Marjorie Luckey, MD Thyroid Disease and Bone Loss, David Cooper, MD Chronic Kidney Disease and Bone Health, Paul Miller, MD 1:15 p.m. Plenary Identification and Management of Osteoporosis: Maximizing the Utility of DXA and Risk Factors Use of Biochemical Markers in Osteoporosis Management, Michael Kleerekoper, MD Interpreting the DXA Report and Vertebral Fracture Assessment, E. Michael Lewiecki, MD Utilizing Risk Factors in Assessing Fracture Risk and Targeting Treatment, Ethel Siris, MD 3:00 p.m. Concurrent Sessions Premenopausal Skeletal Development Prenatal and Early Postnatal Skeletal Development, Winston Koo, MD Adolescent Skeleton, Catherine Gordon, MD Relationships between Birth Control, Depo Provera, Pregnancy, Lactation and Bone Health, MaryFran Sowers, MD Osteoporosis in Men Diagnosis, Treatment, Risk Factors and the NOF Clinical Guidelines for Men  with Osteoporosis, Eric Orwoll, MD Male Spinal Cord Injury and Bone, Robert Adler, MD Determinants of Initiation and Continuation of Antiresorptive Therapy            Role of Primary Care for Osteoporosis Management, Vernon J. Hershberger, MD      How and How Long to Treat Osteoporosis, Juliet Compston, MD The Positive Role of Exercise in Good Posture, Safe Body Mechanics, and Return to Function After Fracture Posture and Body Mechanics, Carleen Lindsey, PT Exercise to Return to Function After Vertebral Fracture, Kathy Shipp, PT Post Hip Fracture Care, Jay Magaziner, PhD New Concepts in the Physiology of Skeletal Health             Pathogenetic Mechanisms in Bone Loss, Lawrence Raisz, MD             Genetics of Bone, Joseph Zmuda, PhD Friday, April 3, 2009 8:00 a.m.  Plenary Osteoporosis: Diseases and Bone Loss             Osteoporosis and the Bowel: What’s the Link?, Peter Green, MD             Renal Calculi, Hypercalcemia and Hypercalciuria, Murray Favus, MD             Weight Loss, Bariatric Surgery and Bone, Jeffrey Mechanick, MD             Eating Disorders and Bone Loss, Madhu Misra, MD 9:45 a.m. Poster Presentations and Exhibit Hall Break 10:45 a.m. Meet the Professor Sessions Premenopausal Women, Elizabeth Shane, MD Kyphoplasty and Vertebroplasty, Mary E. Jensen, MD Fundamentals and Pitfalls of DXA Interpreting: Physician and Technologist Interactive Session, Nelson Watts, MD and JoAnn Caudill, RT Patient and Professional Education in Osteoporosis, Daniel Solomon, MD Nutrition and Osteoporosis, Connie Weaver, PhD 1:00 p.m. Plenary Non-Pharmacological Issues in Osteoporosis Management I             Calcium and Vitamin D, Bess Dawson-Hughes, MD             Exercise Prescription for Osteoporosis, Karen Kemmis, DPT             Osteoporosis Treatments: Compliance and Persistence, Deborah T. Gold, PhD             Nutraceuticals: Effects on Bone Metabolism, Jeri Nieves, PhD 2:45 p.m. Plenary Osteoporosis: Medication, Disease and Bone Loss             Cancer Therapy-Induced Bone Loss in Women, Robert Gagel, MD             Cancer Therapy-Induced Bone Loss in Men, Susan Greenspan, MD             Glucocorticoid-Induced Bone Loss, Kenneth Saag, MD             PPIs, Anticoagulants and Antiseizure Medications and Bone Loss, Mary Beth                     O’Connell, PharmD 4:30 p.m. Plenary Coalition for a National Action Plan on Bone Health: Bone Summit Panel Discussion             Panelists:             Leo Schargorodski             Joan McGowan, PhD             Robert Gagel, MD Saturday, April 4, 2009 8:00 a.m. Plenary Disease and Therapy-Induced Bone Loss             Diabetes and Its Treatment: Outcomes for Bone, John Bilezikian, MD             Stroke, Parkinson’s Disease and Bone Health, F. Michael Gloth III, MD             Depression and Bone, Jonathan D. Adachi, MD             Rheumatoid Arthritis and Connective Tissue Disease: Their Impact on Bone, Chad Deal, MD 9:45 a.m. Poster Presentations and Exhibit Hall Break  10:45 a.m. Meet the Professor Sessions Premenopausal Women, Elizabeth Shane, MD Kyphoplasty and Vertebroplasty, Mary E. Jensen, MD Fundamentals and Pitfalls of DXA Interpreting: Physician and Technologist Interactive Session, Nelson Watts, MD and JoAnn Caudill, RT Low Peak Bone Mass: When is it Real and When a Fiction?, Robert Lindsay, MD, PhD Nutrition and Osteoporosis, Connie Weaver, PhD  1:00 p.m. Plenary Non-Pharmacological Issues in Osteoporosis Management II             Fall Prevention, Stephanie Studenski, MD             Osteoporosis in the Long Term Care Setting, Douglas Kiel, MD             Osteoporosis and Its Effect on Quality of Life, Stuart Silverman, MD 2:45 p.m. Case Studies Early Postmenopausal Women and Bone, Margery Gass, MD Role of Advanced Practice Clinicians (NPs and PAs) in Prevention and Identification of Osteoporosis, Adrienne Berarducci, PhD, ARNP and Rick Pope, PA-C Subtrochanteric and Stress Fractures,  Joseph Lane, MD Sunday, April 5, 2009 8:00 a.m. Plenary FDA-Approved Therapies for Osteoporosis             Bisphosphonates for Osteoporosis: Current Uses and Challenges, Steven Harris, MD             Anabolic Therapy for Osteoporosis, Felicia Cosman, MD             Hormonal Therapies for Osteoporosis: Estrogen, Calcitonin and EEAs (SERMs), Robert Lindsay, MD, PhD             Treatment of Osteoporosis in the Setting of Hypogonadism: Use of Testosterone and             Other Agents, Benjamin Leder, MD 10:15 a.m. Plenary Emerging Therapies and Diagnostic Techniques             Bone Quality: New Imaging to Refine Fracture Risk and Improve Therapy, Mary Bouxsein, PhD and David Dempster, PhD             Emerging Pharmaceutical Therapies: Denosumab and New EEAs, Michael McClung, MD